Compugen Ltd. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,549.00
12,367.00
9,277.00
712.00
-
17,800
Cost of Goods Sold (COGS) incl. D&A
2,509.00
3,344.00
1,633.00
1,707.00
1,593.00
2,428
Gross Income
1,040.00
9,023.00
7,644.00
995.00
1,593.00
15,372
SG&A Expense
18,298.00
21,360.00
28,562.00
31,588.00
35,812.00
38,599
EBIT
17,258.00
12,337.00
20,918.00
32,583.00
37,405.00
23,227
Unusual Expense
707.00
269.00
-
-
-
-
Non Operating Income/Expense
4,241.00
1,159.00
390.00
392.00
169.00
8
Interest Expense
28.00
16.00
60.00
23.00
15.00
23
Pretax Income
13,583.00
10,579.00
19,773.00
31,486.00
37,066.00
22,599
Income Tax
500.00
360.00
390.00
20.00
-
-
Equity in Affiliates
-
155.00
-
-
-
-
Consolidated Net Income
14,083.00
11,094.00
20,163.00
31,506.00
37,066.00
22,599
Net Income
14,083.00
11,094.00
20,163.00
31,506.00
37,066.00
22,599
Net Income After Extraordinaries
14,083.00
11,094.00
20,163.00
31,506.00
37,066.00
22,599
Net Income Available to Common
14,083.00
11,094.00
20,163.00
31,506.00
37,066.00
22,599
EPS (Basic)
0.36
0.23
0.40
0.62
0.72
0.41
Basic Shares Outstanding
38,869.40
47,808.90
50,437.00
50,855.90
51,179.70
55,277.40
EPS (Diluted)
0.36
0.23
0.40
0.62
0.72
0.41
Diluted Shares Outstanding
38,869.40
48,387.10
50,437.00
50,855.90
51,179.70
55,277.40
EBITDA
16,888.00
11,679.00
19,812.00
31,099.00
35,812.00
21,833
Non-Operating Interest Income
169.00
346.00
815.00
728.00
523.00
643

About Compugen

View Profile
Address
Azrieli Center
Holon TA 58858
Israel
Employees -
Website http://www.cgen.com
Updated 07/08/2019
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.